RBA
MRNA icon

Richard Bernstein Advisors’s Moderna MRNA Stock Holding History

Richard Bernstein Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-13,919
Closed -$1.44M – 230
2023
Q3 		$1.44M Hold
13,919
– – 0.03% 186
2023
Q2 		$1.69M Hold
13,919
– – 0.04% 156
2023
Q1 		$2.14M Hold
13,919
– – 0.05% 154
2022
Q4 		$2.5M Buy
+13,919
New +$2.28M 0.06% 140
2022
Q1 		– Sell
-10,517
Closed -$2.67M – 273
2021
Q4 		$2.67M Buy
+10,517
New +$3.07M 0.05% 179

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Richard Bernstein Advisors's MRNA Position: Q4 2023 in Review

Richard Bernstein Advisors sold out of Moderna (MRNA) in Q4 2023, closing a stake of 13,919 shares — an estimated $1.44M sold.

Richard Bernstein Advisors first reported a position in MRNA in Q4 2021 and held it in 5 quarters. The position peaked at $2.67M in Q4 2021. 884 funds tracked by Wall St. Rank hold MRNA as of Q4 2023.

  • Richard Bernstein Advisors reported no remaining Moderna position as of Q4 2023 after selling out during the quarter.
  • Richard Bernstein Advisors sold 13,919 Moderna shares in Q4 2023, an estimated $1.44M.
  • Richard Bernstein Advisors first reported a position in Moderna in Q4 2021 and held it in 5 quarters.
  • Richard Bernstein Advisors's Moderna position peaked at $2.67M in Q4 2021.
  • 884 funds tracked by Wall St. Rank held Moderna as of Q4 2023.

Based on Richard Bernstein Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.